Rapid induction of transdermal buprenorphine to subcutaneous extended-release buprenorphine for the treatment of opioid use disorder
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Rapid induction of transdermal buprenorphine to subcutaneous extended-release buprenorphine for the treatment of opioid use disorder ; volume:19 ; number:1 ; day:18 ; month:6 ; year:2024 ; pages:1-6 ; date:12.2024
Addiction science & clinical practice ; 19, Heft 1 (18.6.2024), 1-6, 12.2024
- Creator
-
Azar, Pouya
Schneiderman, Hannah
Barron, Henry
Wong, James S. H.
Meyer, Maximilian
Newman-Azar, Dayyon
Narimani, Matin
Ignaszewski, Martha J.
Mathew, Nickie
Mullen, Rodney
Krausz, Reinhard M.
Maharaj, Anil R.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13722-024-00479-1
- URN
-
urn:nbn:de:101:1-2409110921305.350670777334
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
- 15.08.2025, 7:27 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Azar, Pouya
- Schneiderman, Hannah
- Barron, Henry
- Wong, James S. H.
- Meyer, Maximilian
- Newman-Azar, Dayyon
- Narimani, Matin
- Ignaszewski, Martha J.
- Mathew, Nickie
- Mullen, Rodney
- Krausz, Reinhard M.
- Maharaj, Anil R.
- SpringerLink (Online service)
Other Objects (12)
Transdermal buprenorphine in cancer pain and palliative care
Patients' perspectives on buprenorphine subcutaneous implant: a case series
Long-term low-dose transdermal buprenorphine therapy for chronic noncancer pain
Examining the benefit of a higher maintenance dose of extended-release buprenorphine in opioid-injecting participants treated for opioid use disorder
Single high-dose buprenorphine for opioid craving during withdrawal
Buprenorphine–cannabis interaction in patients undergoing opioid maintenance therapy
Population Pharmacokinetic Analysis Supports Initiation Treatment and Bridging from Sublingual Buprenorphine to Subcutaneous Administration of a Buprenorphine Depot (CAM2038) in the Treatment of Opioid Use Disorder
Perceptions of extended-release naltrexone, methadone, and buprenorphine treatments following release from jail
Perceptions of extended-release buprenorphine among people who received medication for opioid use disorder in jail: a qualitative study
Buprenorphine extended-release injection (Brixadi®) in the management of opioid use disorder: a profile of its use in the USA
Pharmacokinetic-pharmacodynamic analysis of drug liking blockade by buprenorphine subcutaneous depot (CAM2038) in participants with opioid use disorder
Buprenorphine - the unique opioid analgesic : pharmacology and clinical application ; 13 tables
Transdermal buprenorphine in cancer pain and palliative care
Patients' perspectives on buprenorphine subcutaneous implant: a case series
Long-term low-dose transdermal buprenorphine therapy for chronic noncancer pain
Examining the benefit of a higher maintenance dose of extended-release buprenorphine in opioid-injecting participants treated for opioid use disorder
Single high-dose buprenorphine for opioid craving during withdrawal
Buprenorphine–cannabis interaction in patients undergoing opioid maintenance therapy
Population Pharmacokinetic Analysis Supports Initiation Treatment and Bridging from Sublingual Buprenorphine to Subcutaneous Administration of a Buprenorphine Depot (CAM2038) in the Treatment of Opioid Use Disorder
Perceptions of extended-release naltrexone, methadone, and buprenorphine treatments following release from jail
Perceptions of extended-release buprenorphine among people who received medication for opioid use disorder in jail: a qualitative study
Buprenorphine extended-release injection (Brixadi®) in the management of opioid use disorder: a profile of its use in the USA
Pharmacokinetic-pharmacodynamic analysis of drug liking blockade by buprenorphine subcutaneous depot (CAM2038) in participants with opioid use disorder
Buprenorphine - the unique opioid analgesic : pharmacology and clinical application ; 13 tables
Transdermal buprenorphine in cancer pain and palliative care
Patients' perspectives on buprenorphine subcutaneous implant: a case series
Long-term low-dose transdermal buprenorphine therapy for chronic noncancer pain
Examining the benefit of a higher maintenance dose of extended-release buprenorphine in opioid-injecting participants treated for opioid use disorder
Single high-dose buprenorphine for opioid craving during withdrawal
Buprenorphine–cannabis interaction in patients undergoing opioid maintenance therapy
Population Pharmacokinetic Analysis Supports Initiation Treatment and Bridging from Sublingual Buprenorphine to Subcutaneous Administration of a Buprenorphine Depot (CAM2038) in the Treatment of Opioid Use Disorder
Perceptions of extended-release naltrexone, methadone, and buprenorphine treatments following release from jail
Perceptions of extended-release buprenorphine among people who received medication for opioid use disorder in jail: a qualitative study
Buprenorphine extended-release injection (Brixadi®) in the management of opioid use disorder: a profile of its use in the USA
Pharmacokinetic-pharmacodynamic analysis of drug liking blockade by buprenorphine subcutaneous depot (CAM2038) in participants with opioid use disorder